Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma
Clinical trial NCT07676877 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07676877
- Sponsor
- Nathan Denlinger
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-12-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.